Slingshot Bio Launches ViaComp® Ultra Amine: A Next-Generation Cell Mimic for Amine-Reactive Viability and Antibody Compensation in Multiparameter Flow Cytometry

Source: PRNewswire· August 17, 2026

Purpose-engineered cell-like controls deliver improved positive/negative separation, broad species compatibility, and a liquid, non-biohazardous ready-to-use format EMERYVILLE, Calif., Aug. 17, 2026 /PRNewswire/ -- Slingshot Bio, Inc., a leader in precision c…

This story was reported by PRNewswire. Read the full original article:

Read on PRNewswire

More in Products & Launches

View all

CoreWeave for $105: A Reasonable Bull Case On Offer

The post CoreWeave for $105: A Reasonable Bull Case On Offer appeared first on 24/7 Wall St.. CoreWeave (NASDAQ:CRWV) at $105.26 screens attractively for investors underwriting AI infrastructure demand. The market is offering a specialized AI infrastructure o…

Biztoc.com · Aug 17, 2026

The Market Is Sending a Signal And These Stocks Stand Out

The post The Market Is Sending a Signal And These Stocks Stand Out appeared first on 24/7 Wall St.. The AI infrastructure trade keeps accelerating, and three names are flashing the same signal: accelerating orders, expanding margins, and forward visibility th…

Biztoc.com · Aug 17, 2026

American Airlines Changed Passengers’ Flights Without Asking. Its System Reportedly Had No Human Oversight

As more carriers look to integrate AI into their operating systems, experts warn that these cases could be part of a larger issue.

Biztoc.com · Aug 17, 2026

IBM’s Strengths Are The Reason to Buy Today at $234

The post IBM’s Strengths Are The Reason to Buy Today at $234 appeared first on 24/7 Wall St.. IBM (NYSE:IBM) at $234.32 is a Buy. The stock has rebounded 11.74% in the last month off a mid-July capitulation, and the drivers of that rebound remain intact. IBM …

Biztoc.com · Aug 17, 2026